Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to FULC. [ FAQ on what and how to ask] For non-FULC questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 26 Landsdowne Street, Cambridge, MA, United States, 02139
Employees: 9
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders. It has licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
CEO, President & Director
CFO, Treasurer & Principal Accounting Officer
Chief Legal Officer, Head of External Affairs & Corporate Secretary
Founder
Founder
Founder
Founder
Founder
Senior Vice President of Early Development
Head of Program Strategy & Vice President
My Watchlist
